Cargando…
Pathology Examination of Breast Reduction Specimens: Dispelling the Myth
BACKGROUND: More than 100,000 reduction mammaplasties are performed in the United States each year. There is large variance in reported incidence of cancerous/high-risk lesions, ranging from 0.06% to 4.6%. There has been debate whether histological review of breast reduction specimen is necessary. T...
Autores principales: | Fisher, Mark, Burshtein, Aaron L., Burshtein, Joshua G., Manolas, Panagiotis, Glasberg, Scot B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722611/ https://www.ncbi.nlm.nih.gov/pubmed/33299718 http://dx.doi.org/10.1097/GOX.0000000000003256 |
Ejemplares similares
-
Myth Dispelled
por: Possner, Adam
Publicado: (2013) -
Breast Implant-associated Squamous Cell Carcinoma: Initial Review and Early Recommendations
por: Glasberg, Scot B., et al.
Publicado: (2023) -
Farming fit? Dispelling the Australian agrarian myth
por: Brumby, Susan, et al.
Publicado: (2011) -
It’s Time to Dispel the Myth of “Asymptomatic” Schistosomiasis
por: King, Charles H.
Publicado: (2015) -
Comeback of ketamine: resurfacing facts and dispelling myths
por: Kumar, Abhijit, et al.
Publicado: (2021)